Lantern Pharma
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
Domain
lanternpharma.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$1.6M
Founded
2012
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does Lantern Pharma use?+
Lantern Pharma uses 24 technologies including Adobe Fonts, Facebook Pixel, FingerprintJS.
What industry is Lantern Pharma in?+
Lantern Pharma operates in the Artificial Intelligence (AI) industry.
Where is Lantern Pharma based?+
Lantern Pharma is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026